MolNFT v1 · #54224 · protein
Pilus-presented adhesin, SPY0125 (cpa), P212121 form (dls)
2XID · Ancillary protein 1: “Pilus-presented adhesin, SPY0125 (cpa), P212121 form (dls)”. X-ray diffraction, 9 pockets (best druggability 0.74). MolNFT v1 #54224 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2XID
- Type
- protein
- Length
- 846 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ancillary protein 1
- UniProt
- Q8GRA2
- Pockets
- 9 · best druggability 0.74
Structure
x-ray diffraction · 2 distinct chains · 13% helix, 38% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ancillary protein 1 | protein | 416 | 13% helix, 37% strand | Q8GRA2 |
| B | Ancillary protein 1 | protein | 430 | 12% helix, 38% strand | Q8GRA2 |
Pockets
9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 782 | 0.74 | 0.79 | 74 | empty |
| 2 | 271 | 0.54 | 0.76 | 28 | empty |
| 3 | 87 | 0.45 | 0.81 | 16 | empty |
| 4 | 114 | 0.42 | 0.77 | 20 | empty |
| 5 | 147 | 0.40 | 0.74 | 31 | empty |
Interfaces
1 interface between chains.
- A–B · 783 Ų buried · 2 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 isopeptide (isopeptide).
Compared structures
- 2XID · Pilus-presented adhesin, Spy0125 (Cpa), P212121 form (DLS) · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8GRA2
- Elsewhere: RCSB PDB 2XID · PDBe 2XID · UniProt Q8GRA2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.